📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti (2024)

First Author: Antony Oliver M

Attributed to: Infrastructure and Services - Capacity Building funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/cid/ciae108

PubMed Identifier: 38662697

Publication URI: http://europepmc.org/abstract/MED/38662697

Type: Journal Article/Review

Parent Publication: Clinical Infectious Diseases

Issue: Supplement_2

ISSN: 1058-4838